Bayer Expands Men’s Healthcare Portfolio Licence Agreement For Innovative Testosterone Gel

Bayer Schering Pharma will develop and commercialise ProStrakan’s Tostrex® in Canada, Latin America, the Middle East, Africa, Asia and the Pacific region. A respective agreement between Bayer Schering Pharma and ProStrakan Group plc. was signed which grants Bayer exclusive marketing rights in these regions.

More: continued here

Filed under: Endocrinology on December 6th, 2008